245 related articles for article (PubMed ID: 21895787)
1. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran.
Szigeti G; Sedaghati E; Mahmoudabadi AZ; Naseri A; Kocsubé S; Vágvölgyi C; Varga J
Mycoses; 2012 Jul; 55(4):333-8. PubMed ID: 21895787
[TBL] [Abstract][Full Text] [Related]
2. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.
Kamali Sarwestani Z; Hashemi SJ; Rezaie S; Gerami Shoar M; Mahmoudi S; Elahi M; Bahardoost M; Tajdini A; Abutalebian S; Daie Ghazvini R
J Mycol Med; 2018 Jun; 28(2):279-284. PubMed ID: 29540288
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
Halvaeezadeh M; Jalaee GA; Fatahinia M; Mahmoudabadi AZ
Microb Pathog; 2023 Aug; 181():106180. PubMed ID: 37257666
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.
Szigeti G; Kocsubé S; Dóczi I; Bereczki L; Vágvölgyi C; Varga J
Mycopathologia; 2012 Aug; 174(2):143-7. PubMed ID: 22359155
[TBL] [Abstract][Full Text] [Related]
5. The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan.
Hagiwara S; Tamura T; Satoh K; Kamewada H; Nakano M; Shinden S; Yamaguchi H; Makimura K
Mycopathologia; 2019 Feb; 184(1):13-21. PubMed ID: 30291485
[TBL] [Abstract][Full Text] [Related]
6. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of otomycosis in Khouzestan Province, south-west Iran.
Saki N; Rafiei A; Nikakhlagh S; Amirrajab N; Saki S
J Laryngol Otol; 2013 Jan; 127(1):25-7. PubMed ID: 23164073
[TBL] [Abstract][Full Text] [Related]
9. Cryptic species and azole resistance in the Aspergillus niger complex.
Howard SJ; Harrison E; Bowyer P; Varga J; Denning DW
Antimicrob Agents Chemother; 2011 Oct; 55(10):4802-9. PubMed ID: 21768508
[TBL] [Abstract][Full Text] [Related]
10. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
[TBL] [Abstract][Full Text] [Related]
11. Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
Jing R; Yang WH; Xiao M; Li Y; Zou GL; Wang CY; Li XW; Xu YC; Hsueh PR
J Microbiol Immunol Infect; 2022 Apr; 55(2):282-290. PubMed ID: 33839057
[TBL] [Abstract][Full Text] [Related]
12. Drug Sensitivity and Resistance Mechanism in Aspergillus Section
Hashimoto A; Hagiwara D; Watanabe A; Yahiro M; Yikelamu A; Yaguchi T; Kamei K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607016
[No Abstract] [Full Text] [Related]
13. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent.
Sabz G; Gharaghani M; Mirhendi H; Ahmadi B; Gatee MA; Sisakht MT; Hemati A; Mohammadi R; Taghavi J; Nouripour-Sisakht S
J Med Microbiol; 2019 Apr; 68(4):585-590. PubMed ID: 30801244
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
15. Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
Vermeulen E; Maertens J; Meersseman P; Saegeman V; Dupont L; Lagrou K
Clin Microbiol Infect; 2014 May; 20(5):O333-5. PubMed ID: 24102876
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.
Nosratabadi M; Espahbodi A; Hedayati MT; Shokohi T; Badali H; Saeedi M; Moazeni M; Aghili SR; Javidnia J; Faeli L; Khojasteh S; Roohi B; Abbasi K; Abastabar M; Haghani I
Mycopathologia; 2023 Apr; 188(1-2):119-127. PubMed ID: 36449121
[TBL] [Abstract][Full Text] [Related]
17. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
Hendrickx M; Beguin H; Detandt M
Mycoses; 2012 Mar; 55(2):148-55. PubMed ID: 21929560
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Aspergillus Strains Identification and Antifungal Susceptibility Analysis of 452 Cases with Otomycosis in Jingzhou, China.
Peng D; Li A; Kong M; Mao C; Sun Y; Shen M
Mycopathologia; 2024 Apr; 189(2):30. PubMed ID: 38578519
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus tubingensis and Aspergillus niger as the dominant black Aspergillus, use of simple PCR-RFLP for preliminary differentiation.
Mirhendi H; Zarei F; Motamedi M; Nouripour-Sisakht S
J Mycol Med; 2016 Mar; 26(1):9-16. PubMed ID: 26852194
[TBL] [Abstract][Full Text] [Related]
20. Aspergillus niger contains the cryptic phylogenetic species A. awamori.
Perrone G; Stea G; Epifani F; Varga J; Frisvad JC; Samson RA
Fungal Biol; 2011 Nov; 115(11):1138-50. PubMed ID: 22036292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
